BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35545892)

  • 21. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic obstructive pulmonary disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes, prognostic markers, and functional status changes.
    Mok M; Nombela-Franco L; Dumont E; Urena M; DeLarochellière R; Doyle D; Villeneuve J; Côté M; Ribeiro HB; Allende R; Laflamme J; DeLarochellière H; Laflamme L; Amat-Santos I; Pibarot P; Maltais F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1072-84. PubMed ID: 24156967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Over diagnosis of chronic obstructive pulmonary disease in an underserved patient population.
    Ghattas C; Dai A; Gemmel DJ; Awad MH
    Int J Chron Obstruct Pulmon Dis; 2013; 8():545-9. PubMed ID: 24348030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fixed ratio or lower limit of normal for the FEV
    Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
    Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Prognostic Long-Term Impact of Chronic Obstructive Pulmonary Disease and Postoperative Mucostasis in Patients with Curatively Resected Non-Small Cell Lung Cancer.
    Lindenmann J; Fediuk M; Fink-Neuboeck N; Mykoliuk I; Taucher E; Pichler M; Smolle J; Smolle-Juettner FM
    Cells; 2023 Feb; 12(3):. PubMed ID: 36766822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Combined Chronic Obstructive Pulmonary Disease Status and Systemic Inflammation on Outcome of Advanced NSCLC: Multicenter Retrospective Cohort Study.
    Lim JU; Kang HS; Yeo CD; Kim JS; Park CK; Kim YH; Kim JW; Kim SJ; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2020; 15():3323-3334. PubMed ID: 33363365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the Spirometry Parameters Between Indigenous and Non-Indigenous Patients with COPD: A Matched Control Study.
    Sze DFL; Howarth TP; Lake CD; Ben Saad H; Heraganahally SS
    Int J Chron Obstruct Pulmon Dis; 2022; 17():869-881. PubMed ID: 35480554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using dynamics of forced expiration to identify COPD where conventional criteria for the FEV₁ /FVC ratio do not match.
    Topalovic M; Exadaktylos V; Decramer M; Berckmans D; Troosters T; Janssens W
    Respirology; 2015 Aug; 20(6):925-31. PubMed ID: 25880716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between chronic obstructive pulmonary disease and lung cancer in African American patients.
    Mina N; Soubani AO; Cote ML; Suwan T; Wenzlaff AS; Jhajhria S; Samarah H; Schwartz AG
    Clin Lung Cancer; 2012 Mar; 13(2):149-56. PubMed ID: 22129972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Additional spirometry criteria predict postoperative complications after coronary artery bypass grafting (CABG) independently of concomitant chronic obstructive pulmonary disease: when is off-pump CABG more beneficial?
    Lizak MK; Nash E; Zakliczyński M; Sliwka J; Knapik P; Zembala M
    Pol Arch Med Wewn; 2009 Sep; 119(9):550-7. PubMed ID: 19776699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhaled medications for chronic obstructive pulmonary disease predict surgical complications and survival in stage I non-small cell lung cancer.
    Tohmasi S; Eaton DB; Heiden BT; Rossetti NE; Rasi V; Chang SH; Yan Y; Gopukumar D; Patel MR; Meyers BF; Kozower BD; Puri V; Schoen MW
    J Thorac Dis; 2023 Dec; 15(12):6544-6554. PubMed ID: 38249867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical treatment for lung cancer with COPD based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD).
    Iwasaki A; Shirakusa T; Enatsu S; Maekawa S; Yoshida Y; Yoshinaga Y
    Thorac Cardiovasc Surg; 2005 Jun; 53(3):162-7. PubMed ID: 15926096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung function impairment in the German Lung Cancer Screening Intervention Study (LUSI): prevalence, symptoms, and associations with lung cancer risk, tumor histology and all-cause mortality.
    Kaaks R; Christodoulou E; Motsch E; Katzke V; Wielpütz MO; Kauczor HU; Heussel CP; Eichinger M; Delorme S
    Transl Lung Cancer Res; 2022 Sep; 11(9):1896-1911. PubMed ID: 36248328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease.
    Chun EM; Kim SW; Lim SY
    Int J Chron Obstruct Pulmon Dis; 2015; 10():955-60. PubMed ID: 26028968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of clinical characteristics to predict spirometric classification of obstructive lung disease.
    Pascoe SJ; Wu W; Collison KA; Nelsen LM; Wurst KE; Lee LA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():889-902. PubMed ID: 29559773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
    Sawa K; Koh Y; Kawaguchi T; Kambayashi S; Asai K; Mitsuoka S; Kimura T; Yoshimura N; Yoshimoto N; Kubo A; Saka H; Matsumura A; Wanibuchi H; Yamamoto N; Nishiyama N; Hirata K
    Lung Cancer; 2017 Oct; 112():96-101. PubMed ID: 29191607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a high-intensity pulmonary rehabilitation program on the minute ventilation/carbon dioxide output slope during exercise in a cohort of patients with COPD undergoing lung resection for non-small cell lung cancer.
    Perrotta F; Cennamo A; Cerqua FS; Stefanelli F; Bianco A; Musella S; Rispoli M; Salvi R; Meoli I
    J Bras Pneumol; 2019; 45(6):e20180132. PubMed ID: 31618297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of the Six-Second Spirometry in Patients with Chronic Obstructive Pulmonary Disease: A Cohort Study.
    Prats E; Tejero E; Pardo P; Gavilán A; Galera R; Donado JR; Racionero MÁ; Casitas R; Zapatero A; García-Río F
    PLoS One; 2015; 10(10):e0140855. PubMed ID: 26489023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.